ProofPilot Announces Inaugural CORE Symposium for Clinical Operations Leaders

NEW YORK, Sept. 11, 2025 /PRNewswire/ — ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), today announced the launch of its inaugural CORE Symposium, a half-day event for clinical operations professionals to tackle the most challenging obstacles in clinical trials recruitment and engagement.

The CORE Symposium will take place on September 22, 2025, at Fenway Park in Boston, from 12:00 to 4:00 pm, and will conclude with an exclusive VIP ballpark tour for attendees.

Designed for candid conversations and collaborative sessions with bold thinkers and dedicated leaders from over 40 different pharma and biotech companies, the event will focus on concrete strategies and solutions to improve clinical trials for sponsors, sites, and patients.

“This isn’t your typical conference,” said Chris Venezia, CEO of ProofPilot. “We created the CORE Symposium because the clinical trials industry needs more space for real talk and actual solutions versus just inspiration. We’ve built an event with a fresh format and a new kind of energy so that attendees walk away with real action plans to enact change.”

The CORE Symposium will feature a keynote address from Gunnar Esiason, Senior Director of Patient Engagement at RA Capital Management’s Raven healthcare incubator, who will share his perspective as a rare disease patient leader and clinical trial participant.

In addition to the keynote are three panel discussions designed to explore tangible solutions to the toughest industry challenges.

  • The Back of a Baseball Card: 360 Stats for High Performing Sites, hosted by Definitive Healthcare
  • The AI Right in Front of Us, hosted by Stark Raving Health
  • Technology Change Management, hosted by Korio

During the symposium, ProofPilot will also present the first-ever Change Agent Awards, recognizing individuals in pharma and biotech who have driven meaningful, scalable change in clinical research for their respective organizations. Nominations are now open; peers and colleagues are welcome to nominate standout leaders who aren’t just talking about innovation, but actually delivering change.

Clinical operations professionals can request an invite or learn more here.

About ProofPilot

ProofPilot modernizes the way clinical trials are launched and managed via its Clinical Experience Platform. With a focus on simplifying site operations and reducing patient burden, the platform deploys a seamless, branded experience from recruitment through close out leading to faster enrollment timelines, higher compliance rates and increased quality for your trials. Learn more at www.proofpilot.com.

Stay informed about ProofPilot news at https://www.linkedin.com/company/proofpilot 

Media Contact: Hope McCain, hope.mccain@proofpilot.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/proofpilot-announces-inaugural-core-symposium-for-clinical-operations-leaders-302553913.html

SOURCE ProofPilot

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

14 minutes ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

5 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

6 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

6 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

6 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

11 hours ago